AbbVie announced a donation of $5 million to Family Reach to support the organization’s efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
